SSC 02 - SSC Session - Lupus Anticoagulant/Antiphospholipid Antibodies

Presentations:

• 2:30 PM – 2:35 PM

  Introduction
  

  Speaker: Hannah Cohen, MD – Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK
• 2:35 PM – 2:50 PM

  Update on New Antiphospholipid Syndrome (APS) Classification Criteria
  

  Speaker: Doruk Erkan, MD – Hospital for Special Surgery - Weill Cornell Medicine
• 2:50 PM – 3:02 PM

  Role of IgG and IgM Antiphosphatidylserine/Prothrombin (aPS/PT) Antibodies in Antiphospholipid syndrome (APS) Risk Assessment
  

  Speaker: Katrien MJ Devreese, MD, PhD – Department of Laboratory Medicine, Department of Diagnostic Sciences, Ghent University Hospital, Ghent University
• 3:02 PM – 3:10 PM

  Update on Standardization of Thrombin Generation Assays 2.0
  

  Speaker: Bas de Laat, MD
• 3:10 PM – 3:20 PM

  Update on POCT INR Monitoring in Antiphospholipid Syndrome (APS) Patients
  

  Speaker: Katrien MJ Devreese, MD, PhD – Department of Laboratory Medicine, Department of Diagnostic Sciences, Ghent University Hospital, Ghent University
• 3:20 PM – 3:35 PM

  Q&A
  

  Speaker: Hannah Cohen, MD – Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK
• 3:35 PM – 3:47 PM

  Results of Survey On Diagnosis and Antithrombotic Treatment in Antiphospholipid syndrome (APS) Patients With Ischaemic Stroke, Other Brain Ischaemic Injury or Arterial Thromboembolism in Other Sites
  

  Speaker: Hannah Cohen, MD – Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK
• 3:47 PM – 3:55 PM

  Update on International Registry of Thrombotic Antiphospholipid Syndrome (APS) Patients Treated With Direct Oral Anticoagulants
  

  Speaker: Stéphane Zuily, MD – Université de Lorraine, Inserm, DCAC and Centre Hospitalier Regional Universitaire de Nancy, Vascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, Nancy, France
• 3:55 PM – 4:05 PM

  Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): Insights From an International Network
  

  Speaker: M Laura Bertolaccini, PhD – King's College London
• 4:05 PM – 4:10 PM

  Update on Controversies in Rheumatology and Autoimmunity (CORA) International Registry: Current Treatments Practice in Women With Obstetric Antibodies in Antiphospholipid syndrome (APS) and Women With Obstetrical Morbidity and “Non-criteria” APS and Adverse Obstetrical Outcomes
  

  Speaker: Cristina Belizna, MD – University Hospital Angers
• 4:10 PM – 4:15 PM

  Update on SKYLARK Project: Successive Follow Up of Antiphospholipid Antibodies Fluctuations in Patients With Clinical Sydney Criteria for Antibodies in Antiphospholipid Syndrome (APS): Long Term Impact for Diagnosis and Outcomes
  

  Speaker: Cristina Belizna, MD – University Hospital Angers
• 4:15 PM – 4:28 PM

  Q&A
  

  Speaker: Hannah Cohen, MD – Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK
• 4:28 PM – 4:30 PM

  Concluding Remarks
  

  Speaker: Hannah Cohen, MD – Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK